Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,863 | 717 | 97.5% |
| Education | $190.70 | 3 | 2.1% |
| Debt forgiveness | $24.38 | 2 | 0.3% |
| Consulting Fee | $14.31 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,357 | 125 | $0 (2024) |
| Amgen Inc. | $996.43 | 90 | $0 (2024) |
| Novo Nordisk Inc | $923.63 | 98 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $811.19 | 45 | $0 (2024) |
| Lilly USA, LLC | $693.09 | 57 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $523.80 | 35 | $0 (2024) |
| Astellas Pharma US Inc | $384.71 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $347.25 | 21 | $0 (2024) |
| PFIZER INC. | $311.37 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $309.08 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,396 | 176 | ABBVIE INC. ($490.45) |
| 2023 | $2,322 | 168 | AbbVie Inc. ($382.83) |
| 2022 | $1,609 | 112 | ABBVIE INC. ($325.89) |
| 2021 | $1,154 | 109 | Biohaven Pharmaceuticals, Inc. ($208.89) |
| 2020 | $512.91 | 54 | Novo Nordisk Inc ($169.14) |
| 2019 | $232.05 | 17 | Amgen Inc. ($45.98) |
| 2018 | $253.03 | 20 | Allergan Inc. ($38.50) |
| 2017 | $613.96 | 69 | Allergan Inc. ($156.92) |
All Payment Transactions
725 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.48 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Divya Batra, MD
Dr. Divya Batra, MD is a Family Medicine healthcare provider based in Quincy, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1780896381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Divya Batra, MD has received a total of $9,093 in payments from pharmaceutical and medical device companies, with $2,396 received in 2024. These payments were reported across 725 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,863).
Practice Information
- Specialty Family Medicine
- Location Quincy, IL
- Active Since 05/04/2007
- Last Updated 02/08/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780896381
Products in Payments
- UBRELVY (Drug) $703.93
- FARXIGA (Drug) $596.49
- Otezla (Drug) $507.04
- NURTEC ODT (Drug) $437.35
- VRAYLAR (Drug) $408.01
- TRINTELLIX (Drug) $315.71
- Kerendia (Drug) $309.08
- JARDIANCE (Drug) $282.17
- QULIPTA (Drug) $269.61
- Ozempic (Drug) $259.36
- MOUNJARO (Drug) $242.28
- TRULICITY (Drug) $216.76
- EVENITY (Biological) $215.34
- Wegovy (Drug) $196.21
- Aimovig (Biological) $194.09
- XARELTO (Drug) $182.88
- Rybelsus (Drug) $155.71
- TRELEGY ELLIPTA (Drug) $137.04
- SPIRIVA RESPIMAT (Drug) $127.47
- Livalo (Drug) $119.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Quincy
Tawny Allen, Do, DO
Family Medicine — Payments: $18,328
Dr. Stefanie Kreamer, M.d, M.D
Family Medicine — Payments: $9,303
Dr. David Brumley, Md, MD
Family Medicine — Payments: $8,781
Richard Noble, Md, MD
Family Medicine — Payments: $8,403
Taylor Moore, Do, DO
Family Medicine — Payments: $7,552
Dr. Kimberly Smith, M.d, M.D
Family Medicine — Payments: $6,934